Dr. Lal Path Labs Ltd. — Board Meeting, 24-07-2026: Outcome of Board Meeting
24-07-2026 | 01:37 pm
24-07-2026 | 01:37 pm
Dr. Lal PathLabs' board approved Q1 consolidated results: Revenue at 797.7 Cr, Profit at 170.5 Cr. Declared INR 5/share interim dividend. Subsidiary plans 80% stake acquisition in Ghana's SHL (38 Cr) and 30% in India's Neuome (3.5 Cr) for expansion & tech.
No comments yet. Be the first to comment!
